ArticleOncotarget2018

Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma.

Nicholas M Szigetvari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.